Who is sponsoring NCT06044181?

NCT06044181 is sponsored by Assiut University.

What drugs are being tested in NCT06044181?

Interventions in NCT06044181: Diode laser photocoagulation..

What condition does NCT06044181 study?

NCT06044181 studies Retinopathy of Prematurity.

Is NCT06044181 still recruiting?

NCT06044181 is currently status unknown. Last updated 13 May 2024.

Last reviewed 2024-05-13 · How we verify

NCT06044181

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Peripheral Avascular Retina in Retinopathy of Prematurity

Status unknown NA Last updated 13 May 2024

What this trial tests

NA trial testing Diode laser photocoagulation. in Retinopathy of Prematurity in 32 participants. Status unknown.

Timeline

1 January 2024

Primary endpoint
1 May 2025

1 November 2025

Quick facts

Lead sponsor	Assiut University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	32
Start date	1 January 2024
Primary completion	1 May 2025
Estimated completion	1 November 2025
Sites	1 location across Egypt

Drugs / interventions tested

Diode laser photocoagulation.

Conditions studied

Retinopathy of Prematurity — all drugs for Retinopathy of Prematurity →

Sponsor

Assiut University

Who can join

Adults 18 Months to 3, any sex, with Retinopathy of Prematurity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Retinopathy of prematurity (ROP) is a widely known retinal vascular disorder in preterm infants and a leading cause of visual disability or blindness in children. Advances in antenatal care have resulted in an increase in the survival rate of infants with extremely low birth weight (BW). Approximately 90% of infants who develop ROP do so by a postmenstrual age of 46.3 weeks. In certain patients with or without treatment, the retina may fail to fully vascularize or may develop vascular abnormalities, thus demonstrating persistent avascular retina (PAR) or anomalous vessel findings at the periphery. Because of the advent of technologies such as ultrawide-field fluorescein angiography (UWFFA) persistent vascular abnormalities can be detected more readily and investigated.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Retinopathy of Prematurity

Currently open trials in the same condition.

NCT05558059 — Imaging Retinal Vasculature in Infant Eyes · recruiting
NCT06672913 — Impact of Standardized Skin-to-Skin Care on Clinical Outcomes in Infants Born ≤ 32 Weeks: A Multicenter Study · NA · recruiting
NCT06109285 — Validation of i-ROP DL to Detect More Than Mild ROP · NA · active not recruiting
NCT06315556 — An Observational Study to Collect Data on How Aflibercept (Eylea) Given Using a Paediatric Dosing Device is Used in Pret · recruiting
NCT06265363 — Evaluation of the Frequency, Risk Factors, and Outcomes of ROP in Infants With a BW >1500 Grs or GA ≥33 Wks in Turkey. · recruiting

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06044181 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 13 May 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06044181.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing